Skip to content
Main Menu
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
Financial Statements-2021
Parent Company Only Financial Statement-2021
Consolidated Financial Statements
-2021
Prev
PREVIOUS
Announcement on the expiry of members of the 4th term Remuneration Committee.
NEXT
The Board of Directors approved Q1 2022 consolidated financial statements.
Next
Investors
Material Information
Board of Directors
Corporate Governance
Organization
Major Internal Policies
Corporate Governance
Committee
Audit Committee
Remuneration Committee
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders' Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investors
